What is Nplate (romiplostim) and what is it FDA-approved for?
Nplate is the brand name for romiplostim, a thrombopoietin (TPO) receptor agonist. In FDA labeling, it is used to treat certain patients with immune (idiopathic) thrombocytopenia (ITP) to increase platelet counts and reduce bleeding risk. The typical use is for adults who have not responded adequately to other ITP treatments. The FDA-approved indications also include pediatric patients in certain age ranges, depending on the specific label language. [1][2]
What conditions does Nplate treat—ITP types, adults vs children?
FDA labeling distinguishes the appropriate patient populations for ITP treatment. It includes immune thrombocytopenia (ITP) where platelet counts are low, with use guided by response to prior therapy and by age-specific labeling for children. [1][2]
How does Nplate work?
Nplate mimics the activity of thrombopoietin by binding and activating the TPO receptor on bone marrow cells, which stimulates platelet production. Clinicians monitor platelet counts and adjust dosing to target a safe range rather than simply maximizing platelets. [1]
How is Nplate given and how is dosing managed?
Nplate is administered as a subcutaneous injection. Dosing is titrated based on platelet response and safety monitoring, with guidance in the FDA-approved prescribing information on when to adjust, hold, or stop dosing to reduce the risk of excessive platelet increases. [1]
What are the main FDA safety concerns and side effects?
FDA labeling highlights risks that include treatment-related increases in platelet counts that can raise concern for clotting events, as well as other adverse reactions reported with romiplostim/ Nplate. The prescribing information includes warnings and precautions and recommended monitoring. [1]
Is Nplate approved for off-label uses?
The FDA-approved uses are defined by the product’s prescribing information and may differ from common off-label practices. If you are looking for a specific off-label scenario, the answer depends on the exact use and the patient population; FDA approval should be checked in the current label. [1][2]
Where to find the official FDA documents for Nplate?
The most reliable sources are the FDA-approved prescribing information and related FDA product labeling/approval records. These include the indications, dosing, contraindications, warnings, and adverse reactions. [1][2]
Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125294
[2] https://www.fda.gov/medicines